PerkinElmer Q3 Revenues Rise 4 Percent | GenomeWeb

NEW YORK (GenomeWeb) – PerkinElmer reported after the close of the market on Thursday that is third quarter revenues were up 3 percent, or 10 percent on a constant-currency basis, compared to the same period a year ago.

For the three months ended Oct. 4, PerkinElmer posted Q3 revenues of $563.4 million, up from $542.0 million for Q3 a year ago and beating analysts' consensus estimate of $554.9 million. The company reported organic revenue growth of 6 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.